After the recent correction, Sun Pharma is trading near its immediate support zone around 1570–1560, where RSI is hovering close to the oversold region (~30–35). This suggests that downside momentum may be limited, and a technical rebound is possible. If the stock holds above 1560, a bounce towards 1620–1645 levels can be expected in the near term. Momentum indicators like RSI and MACD are hinting at a potential reversal if stability is maintained above support.
BUY : SUNPHARMA-EQ( SUNPHARMA ) [3351]
—
by